Skip to content

Clinical trials

Observational Hyperglycemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperglycemia Phase: Observational Country / region: United States Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20063
20077
20083
20092
20103
20111
20122
20152
20162
20174
20181
20191
20214
20222
20234
20243
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Recruiting4
Not yet recruiting2
Enrolling by invitation2
Active, not recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Emory University5
HealthPartners Institute3
University of Colorado, Denver3
University of Minnesota3
Vanderbilt University Medical Center3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
AstraZeneca1
Boston Children's Hospital1
Boston Medical Center1
Columbia University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperglycemia51
Diabetes Mellitus18
Hypoglycemia10
Diabetes Mellitus, Type 28
Diabetes Mellitus, Type 16
Obesity4
Breast Neoplasms2
Cardiomyopathies2
Heart Failure2
Hyperphagia2

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.